Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiotepa pharmacokinetics and QT assessment in pediatric allogeneic hematopoietic progenitor cell transplantation with hepatic impairment
2014-004371-22Phase 4Terminated
- Sponsor
- Adienne
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of thiotepa in Hematopathy (2 cohorts), sponsored by Adienne. Primary endpoint: Apparent total plasma clearance. Started Oct 2014; status: terminated.
02
Drugs
thiotepa
03
Conditions
Hematopathy
Beyond the preview
Go deeper on 2014-004371-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004371-22.